Navigation Links
CEL-SCI Corporation Releases Letter to Shareholders
Date:12/12/2008

VIENNA, Va., Dec. 12 /PRNewswire-FirstCall/ -- The following letter is being released by CEL-SCI CORPORATION (NYSE Alternext US: CVM) to its shareholders:

Dear Fellow Shareholders:

Recently we have had two pieces of important news for CEL-SCI Corporation and its shareholders. First, the U.N. World Health Organization's Agency for Research on Cancer report, in reference to the "cancer burden" wrote that "the global burden doubled in the last 30 years of the 20th Century, and it is estimated that this will double again between 2000 and 2020 and nearly triple by 2030". Cancer will soon become the Number One killer in the world, ahead of heart disease. Those increases are much greater than many people had expected and clearly make our non-toxic Multikine cancer product even more important to develop. Second, we need your help with a legislative proposal advocated by the Biotechnology Industry Organization (BIO) which would help CEL-SCI bring Multikine to market faster. Last, what percentage of people do you think will get cancer and how many of them will die from it? The answer may shake you (see below).

    In this letter I also want to review the general status of our Multikine cancer drug:

        1. In the last few months we have hit major milestones.  We signed a
           Multikine licensing agreement with Teva Pharmaceuticals, a
           multinational pharmaceutical company, which will participate in
           and pay for part of our Phase III trial, we took delivery of our
           new manufacturing facility in Baltimore (see the pictures at
           www.cel-sci.com and click on Updated Pictures of Manufacturing
           Facility), and we extended our existing Multikine partnership with
           Orient Europharma (OEP) of Taiwan to cover a larger territory.
           OEP, like Teva, will participate in and pay for part of the Phase
           III clinical t
'/>"/>
SOURCE CEL-SCI Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. CEL-SCI to Present at the Noble Financial Conference
2. CEL-SCI CORPORATION Manufacturing Facility for Pivotal Phase III Cancer Trial Scheduled to Be Completed During 2008 Third Quarter
3. CEL-SCI Announces Exclusive Licensing Agreement with Teva for Cancer Drug Multikine
4. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
5. CEL-SCI Takes Delivery of New Manufacturing Facility
6. Updated Pictures of CEL-SCI Manufacturing Facility Available Online
7. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
8. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
9. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. BioElectronics Corporation Announces Singapore and Malaysia Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015   SurePure, Inc ... photopurification, announced today that the Company has completed ... continued trading of SurePure ("SURP") securities on OTCQB, ... for entrepreneurial and development stage companies. ... standards and eligibility requirements designed to improve marketplace ...
(Date:3/27/2015)... 2015  CASI Pharmaceuticals, Inc. (Nasdaq: CASI ), ... commercialization of innovative therapeutics addressing cancer and other unmet ... focus on China , today reported ... December 31, 2014.  The Company reported ... share, for the three months ended December 31, 2014.  ...
(Date:3/26/2015)... SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; ... including the appointment of auditors, its annual and special ... "Meeting") was adjourned, as previously disclosed on March 25, ... Toronto time). The date of the ... The Meeting will reconvene at the offices of the ...
(Date:3/26/2015)... March 26, 2015 Neogen Corporation (NASDAQ: ... the third quarter of fiscal 2015, which ended Feb. ... prior year,s $6,575,000. Earnings per share in the current ... Current year-to-date net income increased 17% over prior year ... or $0.56 per share, for the same period a ...
Breaking Biology Technology:SurePure Completes Verification and Approved for Trading on the OTCQB Marketplace 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 4CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 5CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 6SQI Diagnostics Inc. Announces Adjournment of Meeting 2Neogen reports 13% increase in net income 2Neogen reports 13% increase in net income 3Neogen reports 13% increase in net income 4Neogen reports 13% increase in net income 5Neogen reports 13% increase in net income 6Neogen reports 13% increase in net income 7Neogen reports 13% increase in net income 8
... Corporation (NYSE: SHP ) ("ShangPharma" or ... research and development outsourcing company, today announced that ... Commerce as one of the Top Ten Leading ... top ten companies were announced at the Fourth ...
... development of the first self-powered nano-device that can transmit ... ACS,s journal Nano Letters , they say it ... implantable medical sensors, airborne and stationary surveillance cameras and ... independently without batteries on energy collected from the environment. ...
... June 15, 2011 Solid grounding in science is ... of American leaders. From biochemists and pharmacists to physician ... States job market lies in the fields of healthcare ... online survey conducted by Harris Interactive for University ...
Cached Biology Technology:ShangPharma Corporation Named a Top Ten Chinese Outsourcing Enterprise 2Careers in Healthcare and Science? "Not Interested" Say Half of U.S. Teens 2Careers in Healthcare and Science? "Not Interested" Say Half of U.S. Teens 3Careers in Healthcare and Science? "Not Interested" Say Half of U.S. Teens 4
(Date:3/16/2015)... 16, 2015 Between 16 ... present groundbreaking innovations in biometric identification at the ... .      (Photo: http://photos.prnewswire.com/prnh/20150316/735333 ... is well at the forefront: the company,s all ... in Germany . BiometricGate is ...
(Date:3/12/2015)... 12, 2015 Beta Systems ... and access management (IAM) solution for a fixed ... Beta System,s new IAM package, customers benefit from ... from multiple IAM implementations across different industries. The ... well as any necessary services and consulting. It ...
(Date:3/11/2015)... , March 11, 2015   The Sync ... platform to scientifically measure and harness music to ... real-time biometrics and objective measurements of physiology, enabling ... at scale in large populations. It is designed ... and clinicians perform rigorous studies and accelerate the ...
Breaking Biology News(10 mins):DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 3Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 3
... cracked the problem of pod shatter in brassica crops such ... are prone to shatter, causing a 10-25% loss of seeds ... producing a hormone in a specific region of the fruit, ... plant Arabidopsis , completely sealing the seeds inside," says ...
... Paul Anastas, Yale,s Teresa and H. John Heinz III ... to lead the U.S. Environmental Protection Agency,s (EPA,s) Office ... of the Center for Green Chemistry & Green Engineering ... chemical engineering and the School of Forestry & Environmental ...
... alleviate diseases associated with menopause, she didn,t realize her ... hundreds of millions of people. The Northern Arizona ... University of Arizona identified a nontoxic chemical technology that ... feast on crops intended for human consumption. ...
Cached Biology News:Shatter-resistant brassicas 2'Father of green chemistry' Paul Anastas to head EPA research 2NAU discovery could help feed millions 2NAU discovery could help feed millions 3
The AVR9-8 stream-select valve is a 9-port, 8-position valve for use with the BioLogic DuoFlow system. This valve is used for high-pressure stream selection....
... BioGenex Super Sensitive MultiLink IHC ... species-specific secondary antibodies, labeled with ... to the bound primary antibody, ... a Streptavidin-Enzyme conjugate. This kit ...
Sf21 Insect Cells (Live) in Max-XP Medium...
EZ-DeWax is a one-step solution that simultanously removes paraffin from and rehydrates formalin-fixed, paraffin embedded tissue...
Biology Products: